---
document_datetime: 2023-09-21 20:35:35
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ritemvia-epar-all-authorised-presentations_en.pdf
document_name: ritemvia-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7408998
conversion_datetime: 2025-12-24 16:23:43.130394
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                   | Route of Administration longer   | Immediate Packaging authorised   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|---------------------------------------|----------------------------------|----------------------------------|---------------------------|-------------|
| EU/1/17/1207/001 | Ritemvia          | 500 mg     | Concentrate for solution for infusion | Intravenous use                  | vial (glass)                     | 50 ml (10 mg/ml)          | 1 vial      |
| EU/1/17/1207/002 | Ritemvia          | 100 mg     | Concentrate for solution for infusion | Intravenous use                  | vial (glass)                     | 10 ml (10 mg/ml)          | 2 vials     |